Structure—Activity Relationships of Polymyxin Antibiotics
By T. Velkov, P. Thompson, Roger L. Nation, Jian Li. Journal of Medicinal Chemistry, 2010
722 citations recorded by the source corpus.
Tony Velkov,* Philip E. Thompson, Roger L. Nation, and Jian Li* School of Medicine, Deakin University, Pigdons Road, Geelong 3217, Victoria, Australia, Medicinal Chemistry and Drug Action and Facility for Anti-infective Drug Development and Innovation, Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville 3052, Victoria, Australia
Subfields: Molecular Biology, Molecular Medicine, Pharmacology
View Paper: https://www.semanticscholar.org/paper/bb8535a5cc00cedf1d6f0a7b90d7fc269e5cb6c9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Linda Liu
- Ze-Chun Yuan
- Jacqueline Macdonald
- A. Richman
- E. Grady
Citations in the corpus
- Current knowledge and perspectives of Paenibacillus: a review (2016, background): “They are used in ointments, such as the antibiotic creams Neosporin and Polysporin (both contain polymyxin B), for the treatment and prevention of topical skin infections; and as last-resort treatments for multidrug resistant internal infections [108].”